Molecular Endocrinology, Vol 6, 773-785, Copyright © 1992 by Endocrine Society

ARTICLES

Characterization of estrogen receptor variant mRNAs from human breast cancers

H Dotzlaw, M Alkhalaf and LC Murphy
Department of Biochemistry and Molecular Biology, University of Manitoba, Winnipeg, Canada.

The cDNAs for variant estrogen receptor (ER) mRNAs previously identified in human breast cancer biopsy samples have been cloned and characterized. Some of these cDNAs are unique to a tumor sample (e.g. clones 24 and 5), while others are present in multiple breast tumor samples (e.g. clone 4). The 5' ends of the variant cDNAs are essentially identical to sequences present in exons 1, 2, and 3 of the normal ER mRNA. However, at points which mark either the exon 2/intron or exon 3/intron boundaries, the variant cDNA sequences diverge and are unrelated to the normal ER mRNA. The unique sequences of clones 24 and 5 are unknown, and the unique sequence of clone 4 is related to the long interspersed repetitive LINE-1 sequences. The variant mRNAs contain open reading frames which could encode proteins containing known functional domains of the normal ER but missing others. In particular, the hormone binding domain of the normal ER is always missing. Furthermore, some of the variant transcripts may encode other unique proteins. In transient expression assays the proteins encoded by the variant ER mRNAs are unable to activate transcription of an estrogen-responsive reporter gene; neither are they able to modulate the ability of normal ER proteins to activate transcription.

This article has been cited by other articles:

				S. Tchatchou, A. Jung, K. Hemminki, C. Sutter, B. Wappenschmidt, P. Bugert, B. H.F. Weber, D. Niederacher, N. Arnold, R. Varon-Mateeva, et al. A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal women Carcinogenesis, January 1, 2009; 30(1): 59 - 64. [Abstract] [Full Text] [PDF]

				K.-R. Wang, T. Nemoto, and Y. Yokota RFX1 Mediates the Serum-induced Immediate Early Response of Id2 Gene Expression J. Biol. Chem., September 7, 2007; 282(36): 26167 - 26177. [Abstract] [Full Text] [PDF]

				X. Long and K. P. Nephew Fulvestrant (ICI 182,780)-dependent Interacting Proteins Mediate Immobilization and Degradation of Estrogen Receptor-{alpha} J. Biol. Chem., April 7, 2006; 281(14): 9607 - 9615. [Abstract] [Full Text] [PDF]

				V. P. Belancio, D. J. Hedges, and P. Deininger LINE-1 RNA splicing and influences on mammalian gene expression Nucleic Acids Res., March 22, 2006; 34(5): 1512 - 1521. [Abstract] [Full Text] [PDF]

				Y.-L. Low, J. I. Taylor, P. B. Grace, M. Dowsett, S. Scollen, A. M. Dunning, A. A. Mulligan, A. A. Welch, R. N. Luben, K.-T. Khaw, et al. Phytoestrogen Exposure Correlation with Plasma Estradiol in Postmenopausal Women in European Prospective Investigation of Cancer and Nutrition-Norfolk May Involve Diet-Gene Interactions Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 213 - 220. [Abstract] [Full Text] [PDF]

				M. H. Herynk and S. A. W. Fuqua Estrogen Receptor Mutations in Human Disease Endocr. Rev., December 1, 2004; 25(6): 869 - 898. [Abstract] [Full Text] [PDF]

				R. Araki, H. Takahashi, R. Fukumura, F. Sun, N. Umeda, M. Sujino, S.-I. T. Inouye, T. Saito, and M. Abe Restricted Expression and Photic Induction of a Novel Mouse Regulatory Factor X4 Transcript in the Suprachiasmatic Nucleus J. Biol. Chem., March 12, 2004; 279(11): 10237 - 10242. [Abstract] [Full Text] [PDF]

				P. J. Blackshear, J. P. Graves, D. J. Stumpo, I. Cobos, J. L. R. Rubenstein, and D. C. Zeldin Graded phenotypic response to partial and complete deficiency of a brain-specific transcript variant of the winged helix transcription factor RFX4 Development, October 1, 2003; 130(19): 4539 - 4552. [Abstract] [Full Text] [PDF]

				K. Morotomi-Yano, K.-i. Yano, H. Saito, Z. Sun, A. Iwama, and Y. Miki Human Regulatory Factor X 4 (RFX4) Is a Testis-specific Dimeric DNA-binding Protein That Cooperates with Other Human RFX Members J. Biol. Chem., January 4, 2002; 277(1): 836 - 842. [Abstract] [Full Text]

				E. Weiderpass, I. Persson, H. Melhus, S. Wedren, A. Kindmark, and J. A. Baron Estrogen receptor {alpha} gene polymorphisms and endometrial cancer risk Carcinogenesis, April 1, 2000; 21(4): 623 - 627. [Abstract] [Full Text] [PDF]

				E. Leygue, H. Dotzlaw, P. H. Watson, and L. C. Murphy Expression of Estrogen Receptor {beta}1, {beta}2, and {beta}5 Messenger RNAs in Human Breast Tissue Cancer Res., March 1, 1999; 59(6): 1175 - 1179. [Abstract] [Full Text] [PDF]

				M.-H. Jeng, M. A. Shupnik, T. P. Bender, E. H. Westin, D. Bandyopadhyay, R. Kumar, S. Masamura, and R. J. Santen Estrogen Receptor Expression and Function in Long-Term Estrogen-Deprived Human Breast Cancer Cells Endocrinology, October 1, 1998; 139(10): 4164 - 4174. [Abstract] [Full Text] [PDF]

				J. I. Macgregor and V. C. Jordan Basic Guide to the Mechanisms of Antiestrogen Action Pharmacol. Rev., June 1, 1998; 50(2): 151 - 196. [Abstract] [Full Text] [PDF]

				I. Erenburg, B. Schachter, R. M. y Lopez, and L. Ossowski Loss of an Estrogen Receptor Isoform (ER{alpha}{Delta}3) in Breast Cancer and the Consequences of Its Reexpression: Interference with Estrogen-Stimulated Properties of Malignant Transformation Mol. Endocrinol., December 1, 1997; 11(13): 2004 - 2015. [Abstract] [Full Text] [PDF]

				M. B. Martin, P. Garcia-Morales, A. Stoica, H. B. Solomon, M. Pierce, D. Katz, S. Zhang, M. Danielsen, and M. Saceda Effects of 12-O-Tetradecanoylphorbol-13-acetate on Estrogen Receptor Activity in MCF-7 Cells J. Biol. Chem., October 20, 1995; 270(42): 25244 - 25251. [Abstract] [Full Text] [PDF]